Телмира

Телмира (Ticagrelor) is an oral antiplatelet medication used to reduce the risk of blood clots in patients with heart conditions. It belongs to the P2Y12 receptor antagonist class and is prescribed for cardiovascular support. This overview covers key uses, effects, and safety notes for informed use.

Телмира (Ticagrelor) is primarily used to prevent blood clots in people with heart-related conditions, such as after a heart attack or for those with unstable angina. It works by blocking platelets from clumping together, which helps maintain healthy blood flow. Doctors may prescribe it alongside low-dose aspirin for added protection. It is not a painkiller but supports long-term cardiovascular health.

Телмира (Ticagrelor) helps maintain proper blood circulation by reducing the likelihood of blood clots forming in arteries. Users may notice improved stamina during physical activity as the heart works more efficiently. Some people report mild headaches or dizziness when starting treatment, which often lessens over time. It does not provide immediate pain relief but contributes to overall heart function.

Телмира (Ticagrelor) should be taken exactly as prescribed by a healthcare provider. Avoid sudden changes in dosage or stopping the medication without medical advice, as this may increase clot risk. Inform your doctor about any bleeding disorders or upcoming surgeries. Keep the medication in a cool, dry place away from direct sunlight. Regular check-ups may be needed to monitor its effects.

Телмира (Ticagrelor) can interact with other medications that affect blood clotting, such as warfarin or NSAIDs like ibuprofen. Combining it with certain antidepressants or antifungals may alter its effectiveness. Grapefruit juice may also interfere with how the body processes Ticagrelor. Always discuss current medications with a healthcare provider before starting this treatment.